"In fact it amounts to creating a general system of insurance for the provision of drugs. Under the system, the state will subsidise part of the price of the drug dose. But for this system to work we have to assess all the financial outlays, complete the development of standards of medical assistance and introduce the necessary monitoring system including, of course, quality assurance. It is necessary to protect the market from inferior and counterfeit products".